These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 29381831)

  • 1. Ptrf transgenic mice exhibit obesity and fatty liver.
    Li Q; Bai L; Shi G; Zhang L; Dai Y; Liu P; Cong YS; Wang M
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):704-710. PubMed ID: 29381831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase I and transcript release factor transgenic mice show impaired function of hematopoietic stem cells.
    Bai L; Lyu Y; Shi G; Li K; Huang Y; Ma Y; Cong YS; Zhang L; Qin C
    Aging (Albany NY); 2020 Oct; 12(20):20152-20162. PubMed ID: 33087586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis.
    Taniguchi T; Maruyama N; Ogata T; Kasahara T; Nakanishi N; Miyagawa K; Naito D; Hamaoka T; Nishi M; Matoba S; Ueyama T
    PLoS One; 2016; 11(9):e0162513. PubMed ID: 27612189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.
    Hayashi YK; Matsuda C; Ogawa M; Goto K; Tominaga K; Mitsuhashi S; Park YE; Nonaka I; Hino-Fukuyo N; Haginoya K; Sugano H; Nishino I
    J Clin Invest; 2009 Sep; 119(9):2623-33. PubMed ID: 19726876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair.
    Zhu H; Lin P; De G; Choi KH; Takeshima H; Weisleder N; Ma J
    J Biol Chem; 2011 Apr; 286(15):12820-4. PubMed ID: 21343302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTRF acts as an adipokine contributing to adipocyte dysfunctionality and ectopic lipid deposition.
    Perez-Diaz S; Garcia-Sobreviela MP; Gonzalez-Irazabal Y; Garcia-Rodriguez B; Espina S; Arenaz I; Arbones-Mainar JM
    J Physiol Biochem; 2018 Nov; 74(4):613-622. PubMed ID: 29869069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscular dystrophy in PTFR/cavin-1 null mice.
    Ding SY; Liu L; Pilch PF
    JCI Insight; 2017 Mar; 2(5):e91023. PubMed ID: 28289716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of cavin-1 deficiency on lipid metabolism.
    Ding SY; Lee MJ; Summer R; Liu L; Fried SK; Pilch PF
    J Biol Chem; 2014 Mar; 289(12):8473-83. PubMed ID: 24509860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges.
    Liu L; Pilch PF
    Elife; 2016 Aug; 5():. PubMed ID: 27528195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population.
    Verrijken A; Beckers S; Francque S; Hilden H; Caron S; Zegers D; Ruppert M; Hubens G; Van Marck E; Michielsen P; Staels B; Taskinen MR; Van Hul W; Van Gaal L
    Obesity (Silver Spring); 2013 Oct; 21(10):2138-45. PubMed ID: 23512881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cellular senescence by the essential caveolar component PTRF/Cavin-1.
    Bai L; Deng X; Li J; Wang M; Li Q; An W; A D; Cong YS
    Cell Res; 2011 Jul; 21(7):1088-101. PubMed ID: 21445100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and significance of fat mass and obesity associated gene and forkhead transcription factor O1 in non-alcoholic fatty liver disease.
    Zhang J; Li S; Li J; Han C; Wang Z; Li C; Wang X; Liu Z; Wen J; Zheng L
    Chin Med J (Engl); 2014; 127(21):3771-6. PubMed ID: 25382334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E; Morgan K; French SW; Morgan TR
    Nutr Res; 2013 Nov; 33(11):932-41. PubMed ID: 24176233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intervention effect and mechanism of compound Ginkgo biloba preparations on nonalcoholic fatty liver].
    Li HZ; Wang JH; Niu CC; Pan SH
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1580-4. PubMed ID: 26281602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
    Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
    Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver.
    Jadhao SB; Yang RZ; Lin Q; Hu H; Anania FA; Shuldiner AR; Gong DW
    Hepatology; 2004 May; 39(5):1297-302. PubMed ID: 15122758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.
    Cen X; Chen Q; Wang B; Xu H; Wang X; Ling Y; Zhang X; Qin D
    Cell Commun Signal; 2022 Nov; 20(1):191. PubMed ID: 36443833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD.
    Softic S; Boucher J; Solheim MH; Fujisaka S; Haering MF; Homan EP; Winnay J; Perez-Atayde AR; Kahn CR
    Diabetes; 2016 Aug; 65(8):2187-200. PubMed ID: 27207510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution.
    Adiyaman SC; V Schnurbein J; De Laffolie J; Hahn A; Siebert R; Wabitsch M; Kamrath C
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):946-952. PubMed ID: 35405042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.